Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Dr. Reddy’s Laboratories has informed that a meeting of the Board of Directors of the Company will be held on Friday, October 24, 2025, to consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ending on September 30, 2025. Further, the company has informed that, under the provisions of the SEBI (Prohibition of Insider Trading) Regulations, 2015, the trading window for dealing in securities of the Company will be closed from September 24, 2025 to October 26, 2025.
The above information is a part of company’s filings submitted to BSE.
